Evidence map›Paper›PMID 41641818›Full record

ArticleJournal of the American Chemical Society2026

Low-Dimensional Zeotypes Templated by Stacked Cyclic Benzimidazolium Revealed by Electron Crystallography.

Evgeniia Ikonnikova, Jung Cho, Xiaodong Zou, Andre Sutrisno, Allen W Burton, Trong Pham, Tom Willhammar

Abstract read
In one paragraph

Article in Journal of the American Chemical Society, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Evgeniia IkonnikovaDepartment of Chemistry, Stockholm University, Stockholm SE-106 91, Sweden.
Jung ChoDepartment of Chemistry, Stockholm University, Stockholm SE-106 91, Sweden.
Xiaodong ZouDepartment of Chemistry, Stockholm University, Stockholm SE-106 91, Sweden.
Andre SutrisnoExxonMobil Technology & Engineering Company, 1545 Route 22 East, Annandale, New Jersey 08801, United States.
Allen W BurtonExxonMobil Technology & Engineering Company, 1545 Route 22 East, Annandale, New Jersey 08801, United States.
Trong PhamExxonMobil Technology & Engineering Company, 1545 Route 22 East, Annandale, New Jersey 08801, United States.
Tom WillhammarDepartment of Chemistry, Stockholm University, Stockholm SE-106 91, Sweden.ORCID 0000-0001-6120-1218

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The structural diversity of zeolites depends strongly on the use of organic structure-directing agents (OSDAs) that guide their formation. Low-dimensional zeolitic materials, such as layered or chain-like phases, can serve as key intermediates in topotactic condensation pathways, yet the mechanisms governing their formation and transformation remain poorly understood. Here, we report three low-dimensional zeolitic materials, EMM-75P, EM-L01, and EM-L02, synthesized using benzimidazolium cations as OSDAs. Their structures were determined by three-dimensional electron diffraction (3D ED), including the atomic structure of the OSDAs, revealing their confinement within the framework to shed light on their structure-directing role. The bulky benzimidazolium OSDAs prevent the formation of materials with three-dimensional framework structures and instead direct the formation of low-dimensional zeotypes. Upon calcination, the two-dimensional layered aluminosilicate zeotype EMM-75P undergoes topotactic condensation to form a three-dimensional zeolite, EMM-75, with a previously unreported zeolite framework topology. Aluminosilicate EM-L01 is a 2D analogue of

Identifiers

PMID41641818
PMCPMC12921870

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.